We serve 2-bromo-1-cyclopropyl-2-(2-fluorophenyl)ethanone CAS:204205-33-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: 2-bromo-1-cyclopropyl-2-(2-fluorophenyl)ethanone
CAS.NO:204205-33-4
Synonyms:
Ethanone, 2-bromo-1-cyclopropyl-2-(2-fluorophenyl)-
2-Bromo-1-cyclopropyl-2-(2-fluorophenyl)ethanone
Molecular Formula: C11H10BrFO
Molecular Weight: 257.09900
Physical and Chemical Properties:
Density:1.574 g/cm3
Boiling point: 293.012ºC at 760 mmHg
Melting point:/
Flash point:131.009ºC
Refractive index:1.592
Specification:
Appearance: Light yellow to brown liquid
Purity:≥98%
Moisture Content: 0.1%
Impurity: 0.1%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Prasugrel hydrochloride CAS:389574-19-0
Contact us for information like 2-bromo-1-cyclopropyl-2-(2-fluorophenyl)ethanone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Bromo-1-cyclopropyl-2-(2-fluorophenyl)ethanone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Bromo-1-cyclopropyl-2-(2-fluorophenyl)ethanone Use and application,2-Bromo-1-cyclopropyl-2-(2-fluorophenyl)ethanone technical grade,usp/ep/jp grade.
Related News: The ban will be in place for up to 14 days, and is aimed at helping contain the spread of the Wuhan coronavirus. So far, there have been no confirmed coronavirus cases in New Zealand or any South Pacific island.Tetraethyl orthosilicate hydrolyzed manufacturer The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented.acetohydrazide supplier Others — somewhat more cynically — wondered if this was a concerted effort to promote certain herbal products to boost their makers’ share prices ahead of the Chinese stock market’s re-opening Monday.phloroglucinol vendor With the improvement of people’s living standards and the aging degree, the demand for medicines has been increasing for a long time. Therefore, the transfer from finished medicines to bulk medicines has greatly promoted the demand for bulk medicines.The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency.
